Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 1, 2007
Company provides guidance for first quarter 2007December 31, 2006, as well as...
-
Jan 31, 2007
Company will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2006 on Thursday, February 1, at 8:30 a.m.
-
Jan 29, 2007Longer balloon gives physicians broader treatment options in peripheral artery disease
Boston Scientific Corporation (NYSE: BSX) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand its...
-
Jan 25, 2007
The live webcast and archived replay of the Thursday, February 1 call will be available
-
Jan 18, 2007
New U.S. shelf life is longer than any competing drug-eluting stent product
-
Jan 17, 2007
Court orders injunction and damages
-
Jan 16, 2007
U.K. Court of Appeal affirmed an earlier ruling to revoke the U.K. version of a European paclitaxel stent patent owned by Angiotech Pharmaceuticals, Inc.
-
Jan 12, 2007Lower rates of re-intervention and major adverse events reported for the TAXUS Stent in study of diabetic patients
Lower rates of re-intervention and major adverse events reported for the TAXUS Stent in study of diabetic patients
-
Jan 11, 2007
Boston Scientific only company to offer two distinct drug-eluting stent platforms
-
Jan 10, 2007
Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited net sales for its fourth quarter and full year ended December 31,...